These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36698193)

  • 1. Community physicians' attitudes towards meetings with representatives of pharmaceutical companies: a pilot study.
    Koplovitz A; Freud T; Peleg R
    J Pharm Policy Pract; 2023 Jan; 16(1):15. PubMed ID: 36698193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.
    Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Badr K; Akl EA
    BMJ Open; 2014 Jul; 4(7):e004880. PubMed ID: 24989618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
    Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.
    Filippiadou M; Kouvelas D; Garyfallos G; Tsakiridis I; Tzachanis D; Spachos D; Papazisis G
    Ann Med Surg (Lond); 2017 Jul; 19():23-28. PubMed ID: 28603612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and behaviours of physicians towards the relationship with the pharmaceutical industry in Saudi Arabia.
    Bahammam S; Asiri S; Al-Jahdali Y; Baharoon S; Al Shaikh A; Al-Ghamdi M; ALharbi A; Al-Jahdali H
    East Mediterr Health J; 2020 Mar; 26(3):323-330. PubMed ID: 32281642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' perceptions of medical representative visits in Yemen: a qualitative study.
    Al-Areefi MA; Hassali MA; Ibrahim MI
    BMC Health Serv Res; 2013 Aug; 13():331. PubMed ID: 23962304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.
    Hajjar R; Bassatne A; Cheaito MA; Naser El Dine R; Traboulsy S; Haddadin F; Honein-AbouHaidar G; Akl EA
    PLoS One; 2017; 12(9):e0184662. PubMed ID: 28898296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.
    Saito S; Mukohara K; Miyata Y
    PLoS One; 2014; 9(9):e106586. PubMed ID: 25238544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.
    Fadlallah R; Alkhaled L; Brax H; Nasser M; Rajabbik MH; Nass H; Kahale LA; Akl EA
    Eur J Public Health; 2018 Apr; 28(2):224-230. PubMed ID: 29165586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis.
    Salmasi S; Ming LC; Khan TM
    J Pharm Policy Pract; 2016; 9():37. PubMed ID: 27891235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [THE INFLUENCE OF THE ISRAELI LEGISLATION ON THE RELATIONSHIP BETWEEN PHYSICIANS AND PHARMACEUTICAL COMPANIES].
    Nissanholtz-Gannot R; Yankellevich A; Nirel N
    Harefuah; 2016 Jul; 155(7):426-430. PubMed ID: 28514133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation.
    Nissanholtz-Gannot R; Yankellevich A
    Isr J Health Policy Res; 2017 Sep; 6(1):45. PubMed ID: 28946915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
    Chren MM; Landefeld CS
    JAMA; 1994 Mar; 271(9):684-9. PubMed ID: 8309031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pharmaceutical companies' marketing mix strategies on physicians prescribing practices in Jordan: a cross-sectional study.
    Al Thabbah DH; Almahairah MS; Naser AY; Alrawashdeh HM; Araidah M
    BMC Health Serv Res; 2022 Oct; 22(1):1293. PubMed ID: 36303214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between physicians and pharmaceutical representatives, an insight from Thailand.
    Srinonprasert V; Arrunyagasamesuke A; Nimmannit A; Sutheechet K; Wongwatcharadeth P; Phattharayuttawat S; Pongprasobchai S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S223-31. PubMed ID: 24772602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.